Treatment of early Parkinson's disease: Part 2

Tanya Simuni*, Kelly E. Lyons, Rajesh Pahwa, Robert A. Hauser, Cynthia Comella, Lawrence Elmer, Daniel Weintraub

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations


The management of early Parkinson's disease (PD) involves the treatment of motor symptoms, and, increasingly, non-motor symptoms. Given the fast pace of clinical research in PD, clinicians are faced with the challenge of integrating the latest findings into the ongoing care of individual PD patients. Part 1 of this 2-part article reviews efficacy and safety data for the newest PD treatment options, as well as for established therapies. Part 2 of the article, presented here, reviews key data relevant to the assessment of potential neuroprotective therapies and the treatment of non-motor symptoms.

Original languageEnglish (US)
Pages (from-to)206-215
Number of pages10
JournalEuropean Neurology
Issue number4
StatePublished - Mar 2009


  • Dopamine agonists
  • Levodopa
  • Monoamine oxidase B inhibitors
  • Parkinson's disease

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology


Dive into the research topics of 'Treatment of early Parkinson's disease: Part 2'. Together they form a unique fingerprint.

Cite this